gimli
DIVISLAB stock analysis context
DIVI S LABORATORIES Stock Context for AI Screening
DIVI S LABORATORIES LTD is a large-cap stock in Healthcare. This page summarizes key screening signals for DIVI S LABORATORIES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about DIVISLABPrice
₹6,887.00
1M return
+9.57%
3M return
+9.47%
Market cap
₹182,828.21 cr
PE
76.85
ROE
+16.67%
RSI
66.47
Turnover
₹243.90 cr
Why it can matter in screens
- Momentum: DIVISLAB is above 50DMA, above 200DMA; RSI is 66.47.
- Returns: 1M +9.57%, 3M +9.47%, 6M +8.07%.
- Liquidity: latest turnover is ₹243.90 cr.
- Valuation: PE 76.85, PB n/a, ROE +16.67%, ROCE +21.81%.
- Growth: 3Y sales CAGR +1.95%, 3Y profit CAGR -9.54%.
Try these prompts
- Analyze DIVI S LABORATORIES with valuation, momentum and industry peers
- Compare DIVISLAB with other Healthcare stocks
- Show large-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare DIVISLAB with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.